Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology:... International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands var callbackToken='50595FA9E380DCB'; var subCode='aspet_sub'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve Sign In as Member / Individual User Name Password Sign In International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands Arthur Christopoulos , Jean-Pierre Changeux , William A. Catterall , Doriano Fabbro , Thomas P. Burris , John A. Cidlowski , Richard W. Olsen , John A. Peters , Richard R. Neubig , Jean-Philippe Pin , Patrick M. Sexton , Terry P. Kenakin , Frederick J. Ehlert , Michael Spedding , and Christopher J. Langmead Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia (A.C., P.M.S., C.J.L.); Collège de France and CNRS URA 2182, Institut Pasteur, Paris, France (J.-P.C.); Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington (W.A.C.); PIQUR Therapeutics AG, Basel, Switzerland (D.F.); Department of Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, Louisiana (T.P.B.); Signal Transduction Laboratory, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pharmacological Reviews Am. Soc for Pharma & Experimental Therapeutics

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

Pharmacological Reviews , Volume 66 (4): 918 – Oct 1, 2014

Abstract

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands var callbackToken='50595FA9E380DCB'; var subCode='aspet_sub'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve Sign In as Member / Individual User Name Password Sign In International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands Arthur Christopoulos , Jean-Pierre Changeux , William A. Catterall , Doriano Fabbro , Thomas P. Burris , John A. Cidlowski , Richard W. Olsen , John A. Peters , Richard R. Neubig , Jean-Philippe Pin , Patrick M. Sexton , Terry P. Kenakin , Frederick J. Ehlert , Michael Spedding , and Christopher J. Langmead Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia (A.C., P.M.S., C.J.L.); Collège de France and CNRS URA 2182, Institut Pasteur, Paris, France (J.-P.C.); Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington (W.A.C.); PIQUR Therapeutics AG, Basel, Switzerland (D.F.); Department of Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, Louisiana (T.P.B.); Signal Transduction Laboratory,

Loading next page...
 
/lp/am-soc-for-pharma-experimental-therapeutics/international-union-of-basic-and-clinical-pharmacology-xc-multisite-f0a5f3P2dl

References (319)

Publisher
Am. Soc for Pharma & Experimental Therapeutics
Copyright
Copyright © Pharmacological Reviews
ISSN
0031-6997
eISSN
1521-0081
DOI
10.1124/pr.114.008862
pmid
25026896
Publisher site
See Article on Publisher Site

Abstract

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands var callbackToken='50595FA9E380DCB'; var subCode='aspet_sub'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve Sign In as Member / Individual User Name Password Sign In International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands Arthur Christopoulos , Jean-Pierre Changeux , William A. Catterall , Doriano Fabbro , Thomas P. Burris , John A. Cidlowski , Richard W. Olsen , John A. Peters , Richard R. Neubig , Jean-Philippe Pin , Patrick M. Sexton , Terry P. Kenakin , Frederick J. Ehlert , Michael Spedding , and Christopher J. Langmead Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia (A.C., P.M.S., C.J.L.); Collège de France and CNRS URA 2182, Institut Pasteur, Paris, France (J.-P.C.); Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington (W.A.C.); PIQUR Therapeutics AG, Basel, Switzerland (D.F.); Department of Pharmacological & Physiological Science, Saint Louis University School of Medicine, St. Louis, Louisiana (T.P.B.); Signal Transduction Laboratory,

Journal

Pharmacological ReviewsAm. Soc for Pharma & Experimental Therapeutics

Published: Oct 1, 2014

There are no references for this article.